跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 2,357 条关于
“NGM Biopharmaceuticals”
全部
2,357
临床试验
1,209
药物
578
机构
113
资讯
457
去年
NGM Bio Licenses NGM313 to KdT Ventures for Rare Disease Development
去年
NGM Bio Initiates Phase 2 Trial of NGM120 for Hyperemesis Gravidarum Treatment
去年
Xaira Therapeutics Appoints Jeff Jonker as President and COO to Scale AI-Driven Drug Discovery Platform
去年
TCG Labs Soleil Raises $400M to Build Single-Asset Biotech Startups for Strategic Partnerships
去年
Provectus Biopharmaceuticals Launches VisiRose for Ophthalmic Therapies
去年
Angitia Biopharmaceuticals Doses First Patient in Phase 2 Trial of AGA2118 for Osteoporosis
9个月前
SK Biopharmaceuticals' Cenobamate and Solriamfetol Receive NMPA Approval for China Market
9个月前
SK Biopharmaceuticals Licenses WT-7695 Radiopharmaceutical Targeting CA9 for Solid Tumors
11个月前
SK Biopharmaceuticals and Eurofarma Launch AI-Powered Epilepsy Management Joint Venture
去年
Paradigm Biopharmaceuticals Advances Phase 3 Trial for Osteoarthritis Treatment
第 1 页,共 46 页
上一页
下一页